Publication

Acid-suppressive drug use during pregnancy and the risk of atopic dermatitis: A crossover study within the clinical practice research database

Mulder, B., Hak, E., Schuiling-Veninga, C. C. M., De Vries, T. W. & Jick, S. S., Oct-2014, In : Pharmacoepidemiology and Drug Safety. 23, p. 302-303 2 p.

Research output: Contribution to journalMeeting AbstractAcademic

Background: One previous study of our group reported that acid suppressive drug use during pregnancy is associated with an increased risk for the development of atopic dermatitis in children. However, reported associations could have been confounded by unmeasured risk factors. Objectives: The aim of this study was to assess the association between prenatal exposure to acid-suppressive drugs and the development of atopic dermatitis in children by using a confounding minimizing crossover design. Methods: We conducted a bidirectional case-crossover study within the Clinical Practice Research Database in which 1,445 children with atopic dermatitis were randomly matched to one of their own siblings without atopic dermatitis. Children were defined as having atopic dermatitis if they had a diagnosis of atopic dermatitis and at least 3 prescriptions for ointments containing steroids or calcineurin inhibitors in the year after diagnosis. We applied conditional logistic regression to compute odds ratios (ORs) and 95% confidence intervals (95%CI). Results: The percentage of exposure to acid suppressive drugs amongst cases was 21.5% compared to 18.8% amongst controls. After adjustments for gender, birth order and maternal age at delivery the exposure to any acid suppressive drug during pregnancy increased the odds for developing atopic dermatitis by 34% (aOR 1.34; 95%CI: 1.05-1.71). Though not significant, exposure to the subgroup proton pump inhibitors conferred an increased risk of 72% (aOR 1.72 95% CI: 0.62-4.79). Conclusions: This study supports previous findings of a small association between gastric acid suppression during pregnancy and the development of atopic dermatitis in children.
Original languageEnglish
Pages (from-to)302-303
Number of pages2
JournalPharmacoepidemiology and Drug Safety
Volume23
Publication statusPublished - Oct-2014

    Keywords

  • acid, calcineurin inhibitor, steroid, proton pump inhibitor, drug use, pregnancy, risk, atopic dermatitis, crossover procedure, clinical practice, data base, pharmacoepidemiology, risk management, child, human, exposure, diagnosis, birth order, gender, confidence interval, logistic regression analysis, prenatal exposure, stomach acid, ointment, maternal age, prescription, sibling, risk factor

ID: 14307424